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Résumé en
anglais
The impairment of hippocampal neurogenesis at the early stages of Alzheimer's
disease (AD) is believed to support early cognitive decline. Converging studies sustain
the idea that vitamin D might be linked to the pathophysiology of AD and to
hippocampal neurogenesis. Nothing being known about the effects of vitamin D on
hippocampal neurogenesis in AD, we assessed them in a mouse model of AD. In a
previous study, we observed that dietary vitamin D supplementation in female AD-like
mice reduced cognitive decline only when delivered during the symptomatic phase.
With these data in hand, we wondered whether the consequences of vitamin D
administration on hippocampal neurogenesis are stage-dependent. Male wild-type and
transgenic AD-like mice (5XFAD model) were fed with a diet containing either no
vitamin D (0VD) or a normal dose of vitamin D (NVD) or a high dose of vitamin D
(HVD), from month 1 to month 6 (preventive arm) or from month 4 to month 9
(curative arm). Working memory was assessed using the Y-maze, while amyloid
burden, astrocytosis, and neurogenesis were quantified using immunohistochemistry.
In parallel, the effects of vitamin D on proliferation and differentiation were assayed
on primary cultures of murine neural progenitor cells. Improved working memory and
neurogenesis were observed when high vitamin D supplementation was administered
during the early phases of the disease, while a normal dose of vitamin D increased
neurogenesis during the late phases. Conversely, an early hypovitaminosis D
increased the number of amyloid plaques in AD mice while a late hypovitaminosis D
impaired neurogenesis in AD and WT mice. The observed in vivo vitamin D-associated
increased neurogenesis was partially substantiated by an augmented in vitro
proliferation but not an increased differentiation of neural progenitors into neurons.
Finally, a sexual dimorphism was observed. Vitamin D supplementation improved the
working memory of males and females, when delivered during the pre-symptomatic
and symptomatic phases, respectively. Our study establishes that (i) neurogenesis is
improved by vitamin D in a male mouse model of AD, in a time-dependent manner,
and (ii) cognition is enhanced in a gender-associated way. Additional pre-clinical
studies are required to further understand the gender- and time-specific mechanisms
of action of vitamin D in AD. This may lead to an adaptation of vitamin D
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